RedHill Biopharma Ltd. Gains 34.1%
Tue, Oct 17, 2023 at 07:17 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) soared at $0.58, a gain of 34.1%. On Tue, Oct 17, 2023, RDHL:NASDAQ touched a New 2-Week High of $0.58. The stock got featured on our News Catalysts scanner on Tue, Oct 03, 2023 at 09:04 AM in the 'BIOTECH' category. From Tue, Oct 03, 2023, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Oct 17, 2023 at $0.79 with a volume of 23M+.
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- SciSparc Ltd. (SPRC:NASDAQ), 122.97%
- Nkarta Inc. (NKTX:NASDAQ), 112.16%
- Viveve Medical, Inc. (VIVE:NASDAQ), 78.95%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 72.18%
- Olink Holding AB (publ) (OLK:NASDAQ), 66.02%
- Aravive, Inc. (ARAV:NASDAQ), 61.9%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 42.69%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.1%
- Gamer Pakistan Inc. (GPAK:NASDAQ), 32%
- Ramaco Resources, Inc. (METC:NASDAQ), 28.82%